Black mothers are faced with a disproportionate number of barriers to breastfeeding compared to other racial and ethnic groups.

A case of employment termination of a physician assistant (PA) who had a decade’s old contract with her employer. Was the ...

Dr. Renee Wynn is a doctorally educated, board-certified Women's Health Nurse Practitioner who focuses on perinatal and reproductive health justice. She is an Assistant Professor ...

GSK has made the decision to withdraw Jesduvroq (daprodustat) from the US market. Approved in 2023, Jesduvroq, (HIF-PHI), is ...

Significant changes from previous guideline include recommendation that only FSH >25 IU required for POI diagnosis.

The prescribing information for Veozah (fezolinetant) has been updated to include a boxed warning regarding the risk of hepatotoxicity, following the Food and Drug Administration’s review of a ...

The Food and Drug Administration (FDA) has approved Steqeyma ® (ustekinumab-stba), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases in adults and ...

Supplementation with cholecalciferol 1,000 IU/day during pregnancy is associated with greater offspring bone mineral density during childhood.

The approval was based on data from 2 multicenter, randomized, double-blind, vehicle-controlled trials, ADORING 1 and ADORING 2.

Across the last 3 decades, worldwide age-standardized stroke burden rates have declined although some areas have seen increases in disability-adjusted life year rates and age-standardized prevalence, ...

The newly approved regimen is expected to simplify administration and potentially reduce medication errors and dose-related reactions.